JPMorgan Got $400M Before Inovalon Sale, Del. Justices Hear
Inovalon didn't properly disclose that investors that bought the healthcare data company in 2021 paid $400 million in fees to its financial adviser, a JPMorgan unit, before the transaction, a reason...To view the full article, register now.
Already a subscriber? Click here to view full article